CORRECTED-BRIEF-Ardelyx says kidney drug fails phase 2 trial

May 5 (Reuters) - Ardelyx Inc : * Reports results from phase 2a clinical trial evaluating tenapanor in chronic kidney disease patients with type 2 diabetes mellitus and albuminuria * 154-patient phase 2a clinical trial evaluating tenapanor in stage 3 chronic